SS

Sathiyaseelan Swarnasundari

Active Director Director DIN 10552854
DIN 10552854 First appointment Mar 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sathiyaseelan Swarnasundari

Data last updated:

Sathiyaseelan Swarnasundari is a Director at Konak Spira Nutraceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10552854
Primary Designation Director
Industry Pharma
First Appointment 16 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Mar 20242024Active

Board colleagues of Sathiyaseelan Swarnasundari

NameDINCompanyDesignation
Kirubhakaran10552853Konak Spira Nutraceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Konak Spira Nutraceuticals Private Limited
Premium access

Shareholding and investment profile for Sathiyaseelan Swarnasundari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sathiyaseelan Swarnasundari

Sathiyaseelan Swarnasundari currently holds 1 directorship: Konak Spira Nutraceuticals Private Limited (Director, since 16 Mar 2024).

Sathiyaseelan Swarnasundari was first appointed on 16 Mar 2024 as Director at Konak Spira Nutraceuticals Private Limited.

The current boards of Sathiyaseelan Swarnasundari's companies include Kirubhakaran (Konak Spira Nutraceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available